Gut microbiota-mediated pain sensitization: mechanisms and therapeutic implications
- PMID: 40678181
- PMCID: PMC12267181
- DOI: 10.3389/fpain.2025.1626515
Gut microbiota-mediated pain sensitization: mechanisms and therapeutic implications
Abstract
Emerging evidence has illuminated the pivotal role of gut microbiota in modulating pain sensitivity through bidirectional gut-brain interactions. Current research demonstrates that gut microbial communities significantly influence pain perception by regulating both central and peripheral sensitization mechanisms across various pain modalities. This review synthesizes current knowledge on the mechanisms underlying gut microbiota-mediated pain sensitization, encompassing: (1) cross-talk within the microbiome-gut-brain axis, (2) regulatory effects of microbial metabolites on central and peripheral sensitization pathways, and (3) bioactive compounds derived from gut microbiota that participate in pain modulation. Furthermore, we systematically evaluate the therapeutic potential of microbiota-targeted interventions including probiotic supplementation, fecal microbiota transplantation, and dietary modifications in pain management. To advance this promising field, future investigations should prioritize three key directions: establishing causal relationships through rigorous verification, accelerating clinical translation of preclinical findings, and developing personalized microbial-based therapeutic strategies.
Keywords: GPR43; TLR2; gut microbiota; microbiome-gut-brain axis; neuroinflammation; pain; sensitization.
© 2025 Zhao, Zhang and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Gut microbiota-driven neuroinflammation in Alzheimer's disease: from mechanisms to therapeutic opportunities.Front Immunol. 2025 Jun 26;16:1582119. doi: 10.3389/fimmu.2025.1582119. eCollection 2025. Front Immunol. 2025. PMID: 40642089 Free PMC article. Review.
-
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.Int J Mol Sci. 2025 Jun 7;26(12):5486. doi: 10.3390/ijms26125486. Int J Mol Sci. 2025. PMID: 40564947 Free PMC article. Review.
-
Gut microbiota and behavioral ontogeny in autism spectrum disorder: a pathway to therapeutic innovations.Physiol Behav. 2025 Oct 1;299:114989. doi: 10.1016/j.physbeh.2025.114989. Epub 2025 Jun 10. Physiol Behav. 2025. PMID: 40505847 Review.
-
Exploring the gut microbiome's influence on cancer-associated anemia: Mechanisms, clinical challenges, and innovative therapies.World J Gastrointest Pharmacol Ther. 2025 Jun 5;16(2):105375. doi: 10.4292/wjgpt.v16.i2.105375. World J Gastrointest Pharmacol Ther. 2025. PMID: 40575364 Free PMC article.
-
Integrative review of the gut microbiome's role in pain management for orthopaedic conditions.World J Exp Med. 2025 Jun 20;15(2):102969. doi: 10.5493/wjem.v15.i2.102969. eCollection 2025 Jun 20. World J Exp Med. 2025. PMID: 40546666 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources